Shares of Sunshine Biopharma Inc. (SBFM), which gained nearly 25% yesterday, are up another 11% in premarket hours, trading at $3.38.
This pharmaceutical company, focused on oncology and antivirals, recently reported its third-quarter 2024 financial results, reflecting a higher net loss and strong revenue growth.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com